FATE ▲ +0.4% - Fate Therapeutics, Inc. $FATE - Fate Therapeutics Announces Encore Clinical Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate at the CCR – West 2026 Meeting Fate Therapeutics rose 0.4% today following an announcement that the company will present additional clinical data for its FT819 off-the-shelf CAR T-cell candidate at the CCR – West 2026 meeting, signaling continued progress in its cell therapy pipeline. 09-SEP-2026 07:01 AM ET